| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Cash | 2,903,915 | |||
| Prepaid expenses and other current assets, net | 3,128,656 | |||
| Total current assets | 6,032,571 | |||
| Equipment, gross | 1,894,332 | |||
| Less accumulated depreciation | 1,562,986 | |||
| Equipment, net | 331,346 | |||
| Right-of-use assets, net | 65,399 | |||
| Other non-current assets | 83,027 | |||
| Total non-current assets | 479,772 | |||
| Total assets | 6,512,343 | |||
| Accounts payable, accruals, and other current liabilities (including amount due to related parties major stockholders as of june 30, 2025 and 2024, with 172,767 and 113,812 due to related parties related corporations, and 916,036 and 674,262 due to related corporations, respectively ) | 2,853,317 | |||
| Lease payable - current | 35,811 | |||
| Total current liabilities | 2,889,128 | |||
| Amount due to related parties related corporations, non-current-Corporate Joint Venture | 139,772 | |||
| Lease payable non-current | 5,879 | |||
| Total non-current liabilities | 145,651 | |||
| Total liabilities | 3,034,779 | |||
| Common stock 0.001 par value per share as of june 30, 2025 and 2024 400,000,000 and 400,000,000 shares authorized 21,640,000 and 20,000,000 shares issued and outstanding, respectively | 21,640 | |||
| Additional paid-in capital | 21,347,278 | |||
| Accumulated deficits | -19,233,044 | |||
| Accumulated other comprehensive income | 1,341,690 | |||
| Total stockholders equity | 3,477,564 | |||
| Total liabilities and stockholders equity | 6,512,343 | |||
Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. (ADVB)